Kessler RC, Chiu WT, Jin R, Ruscio AM, Shear K, Walters EE. The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2006;63(4):415–24.

Article  PubMed  PubMed Central  Google Scholar 

Kessler RC, Petukhova M, Sampson NA, Zaslavsky AM, Wittchen H-U. Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int J Methods Psychiatr Res. 2012;21(3):169–84.

Article  PubMed  PubMed Central  Google Scholar 

Batinić B, Trajković G, Duisin D, Nikolić-Balkoski G. Life events and social support in a 1-year preceding panic disorder. Psychiatr Danub. 2009;21(1):33–40.

PubMed  Google Scholar 

Zou Z, Huang Y, Wang J, He Y, Min W, Chen X, et al. Association of childhood trauma and panic symptom severity in panic disorder: exploring the mediating role of alexithymia. J Affect Disord. 2016;206:133–9.

Article  PubMed  Google Scholar 

Zhang J, Wiecaszek P, Sami S, Meiser-Stedman R. Association between panic disorder and childhood adversities: a systematic review and meta-analysis. Psychol Med. 2023;53(6):2585–95.

Article  PubMed  Google Scholar 

Claes S. Glucocorticoid receptor polymorphisms in major depression. Ann N Y Acad Sci. 2009;1179:216–28.

Article  CAS  PubMed  Google Scholar 

Denny WB, Valentine DL, Reynolds PD, Smith DF, Scammell JG. Squirrel monkey immunophilin FKBP51 is a potent inhibitor of glucocorticoid receptor binding. Endocrinology. 2000;141(11):4107–13.

Article  CAS  PubMed  Google Scholar 

Harno E, Gali Ramamoorthy T, Coll AP, White A. POMC: the physiological power of hormone Processing. Physiol Rev. 2018;98(4):2381–430.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ehrlich S, Weiss D, Burghardt R, Infante-Duarte C, Brockhaus S, Muschler MA, et al. Promoter specific DNA methylation and gene expression of POMC in acutely underweight and recovered patients with anorexia nervosa. J Psychiatr Res. 2010;44(13):827–33.

Article  PubMed  Google Scholar 

Sinclair D, Fullerton JM, Webster MJ, Shannon Weickert C. Glucocorticoid receptor 1B and 1 C mRNA transcript alterations in schizophrenia and bipolar disorder, and their possible regulation by GR gene variants. PLoS ONE. 2012;7(3):e31720.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Menke A, Klengel T, Rubel J, Brückl T, Pfister H, Lucae S, et al. Genetic variation in FKBP5 associated with the extent of stress hormone dysregulation in major depression. Genes Brain Behav. 2013;12(3):289–96.

Article  CAS  PubMed  Google Scholar 

Fujii T, Hori H, Ota M, Hattori K, Teraishi T, Sasayama D, et al. Effect of the common functional FKBP5 variant (rs1360780) on the hypothalamic-pituitary-adrenal axis and peripheral blood gene expression. Psychoneuroendocrinology. 2014;42:89–97.

Article  CAS  PubMed  Google Scholar 

Lee RS, Mahon PB, Zandi PP, McCaul ME, Yang X, Bali U, et al. DNA methylation and sex-specific expression of FKBP5 as correlates of one-month bedtime cortisol levels in healthy individuals. Psychoneuroendocrinology. 2018;97:164–73.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gatta E, Grayson DR, Auta J, Saudagar V, Dong E, Chen Y, et al. Genome-wide methylation in alcohol use disorder subjects: implications for an epigenetic regulation of the cortico-limbic glucocorticoid receptors (NR3C1). Mol Psychiatry. 2021;26(3):1029–41.

Article  CAS  PubMed  Google Scholar 

Tafet GE, Nemeroff CB. Pharmacological treatment of anxiety disorders: the role of the HPA Axis. Front Psychiatry. 2020;11:443.

Article  PubMed  PubMed Central  Google Scholar 

Flandreau EI, Bourke CH, Ressler KJ, Vale WW, Nemeroff CB, Owens MJ. Escitalopram alters gene expression and HPA axis reactivity in rats following chronic overexpression of corticotropin-releasing factor from the central amygdala. Psychoneuroendocrinology. 2013;38(8):1349–61.

Article  CAS  PubMed  Google Scholar 

Knorr U, Koefoed P, Gluud C, Wetterslev J, Winkel P, Gether U, et al. Effect of escitalopram versus placebo on GRα messenger RNA expression in peripheral blood cells of healthy individuals with a family history of depression - a secondary outcome analysis from the randomized AGENDA trial. Nord J Psychiatry. 2016;70(4):297–302.

Article  PubMed  Google Scholar 

Hinkelmann K, Moritz S, Botzenhardt J, Muhtz C, Wiedemann K, Kellner M, et al. Changes in cortisol secretion during antidepressive treatment and cognitive improvement in patients with major depression: a longitudinal study. Psychoneuroendocrinology. 2012;37(5):685–92.

Article  CAS  PubMed  Google Scholar 

Lenze EJ, Mantella RC, Shi P, Goate AM, Nowotny P, Butters MA, et al. Elevated cortisol in older adults with generalized anxiety disorder is reduced by treatment: a placebo-controlled evaluation of escitalopram. Am J Geriatr Psychiatry. 2011;19(5):482–90.

Article  PubMed  PubMed Central  Google Scholar 

Zou Z, Xiang M, Zhang Y, Huang Y, Wang J, He Y, et al. Associations of DNA methylation of HPA axis-related genes and neuroendocrine abnormalities in panic disorder. Psychoneuroendocrinology. 2022;142:105777.

Article  CAS  PubMed  Google Scholar 

First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV Axis I disorders (SCID-I), Clinical Version. Washington DC, USA: American Psychiatric Press Inc; 1997.

Google Scholar 

Shear MK, Brown TA, Barlow DH, Money R, Sholomskas DE, Woods SW, et al. Multicenter collaborative panic disorder severity scale. Am J Psychiatry. 1997;154(11):1571–5.

Article  CAS  PubMed  Google Scholar 

Xiong HF, Li ZJ, Han HY, Xu ZY, Jiang CQ. Panic disorder severity scale-chinese version: reliability and validity. Chin J Psychiatry. 2012;05:285–8.

Google Scholar 

Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc Ser B. 1995;57:289–300.

Google Scholar 

Zhang S, Cheon M, Park H, Kim T, Chung C. Interaction between glucocorticoid receptors and FKBP5 in regulating neurotransmission of the Hippocampus. Neuroscience. 2022;483:95–103.

Article  CAS  PubMed  Google Scholar 

Wagner KV, Marinescu D, Hartmann J, Wang XD, Labermaier C, Scharf SH, et al. Differences in FKBP51 regulation following chronic social defeat stress correlate with individual stress sensitivity: influence of paroxetine treatment. Neuropsychopharmacology. 2012;37(13):2797–808.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mendonça MS, Mangiavacchi PM, Rios ÁFL. Regulatory functions of FKBP5 intronic regions associated with psychiatric disorders. J Psychiatr Res. 2021;143:1–8.

Article  PubMed  Google Scholar 

Binder EB, Salyakina D, Lichtner P, Wochnik GM, Ising M, Pütz B, et al. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet. 2004;36(12):1319–25.

Article  CAS  PubMed  Google Scholar 

Guidotti G, Calabrese F, Anacker C, Racagni G, Pariante CM, Riva MA. Glucocorticoid receptor and FKBP5 expression is altered following exposure to chronic stress: modulation by antidepressant treatment. Neuropsychopharmacology. 2013;38(4):616–27.

Article  CAS  PubMed  Google Scholar 

Wei K, Xu Y, Zhao Z, Wu X, Du Y, Sun J, et al. Icariin alters the expression of glucocorticoid receptor, FKBP5 and SGK1 in rat brains following exposure to chronic mild stress. Int J Mol Med. 2016;38(1):337–44.

Article  CAS  PubMed  Google Scholar 

Xing Y, Hou J, Meng Q, Yang M, Kurihara H, Tian J. Novel antidepressant candidate RO-05 modulated glucocorticoid receptors activation and FKBP5 expression in chronic mild stress model in rats. Neuroscience. 2015;290:255–65.

Article  CAS  PubMed  Google Scholar 

Binder EB. The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology. 2009;34(Suppl 1):S186–95.

Article  CAS  PubMed  Google Scholar 

Leistner C, Menke A. How to measure glucocorticoid receptor’s sensitivity in patients with stress-related psychiatric disorders. Psychoneuroendocrinology. 2018;91:235–60.

Article  CAS  PubMed  Google Scholar 

Banach E, Szczepankiewicz A, Leszczyńska-Rodziewicz A, Pawlak J, Dmitrzak-Węglarz M, Zaremba D, et al. Venlafaxine and sertraline does not affect the expression of genes regulating stress response in female MDD patients. Psychiatr Pol. 2017;51(6):1029–38.

Article  PubMed  Google Scholar 

Tanay VA, Glencorse TA, Greenshaw AJ, Baker GB, Bateson AN. Chronic administration of antipanic drugs alters rat brainstem GABAA receptor subunit mRNA levels. Neuropharmacology. 1996;35(9–10):1475–82.

Article  CAS  PubMed  Google Scholar 

Kim YR, Park Q, Yu BH. Changes in lymphocyte subsets after short-term pharmacotherapy in patients with panic disorder. Psychiatry Res. 2004;128(2):183–90.

Article  CAS  PubMed  Google Scholar 

Herken H, Akyol O, Yilmaz HR, Tutkun H, Savas HA, Ozen ME, et al. Nitric oxide, adenosine deaminase, xanthine oxidase and superoxide dismutase in patients with panic disorder: alterat